The response of tumors to anticancer drugs has been observed in real-time 3-D images using technology developed at Purdue University. The new digital holographic imaging system uses a laser and the same microchip used in household digital cameras, to see inside tumor cells. The device also may have applications in drug development and medical imaging.
As part of its continuing effort to highlight the critical role that laboratory medicine plays in healthcare, Abbott announced that it has awarded diagnostic equipment, supplies and service to clinical laboratory educational programs at 16 accredited schools across the United States.
On the road to making biofuels more economically competitive with fossil fuels, there are significant potholes to negotiate.
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity.
Errors in stem cell division can give rise to tumours. By studying stem cells in the fruit fly, scientists at the Institute for Research in Biomedicine (IRB Barcelona) have identified one of the mechanisms that govern how these cells divide.
Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure.
A woman who fell ill last month is probably the second human victim of bird flu in Laos, although conclusive test results are still pending, a Health Ministry official said on sunday, reported by Times of India.
A British MP Grant Shapps says “Access to IVF on the NHS is a lottery, with different areas adopting different rules”, reported by BBC.
The Hong Kong Centre for Health Protection (CHP) of the Department of Health received notification from the Ministry of Health concerning a confirmed human case of avian influenza H5N1 in Fujian.
The Hong Kong Department of Health (DH) urged members of the public not to buy or use four brands of health products and two brands of proprietary Chinese medicines after finding them to have contained potentially hazardous ingredients that may cause side effects.